Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats.
作者： Yi Yang , Annette J. Dahly-Vernon , Eric A.G. Blomme , Jie Lai-Zhang , Dale J. Kempf
DOI: 10.1016/J.TVJL.2010.04.017
关键词:
摘要: … , and carbohydrate metabolism, were differentially regulated between the two strains. In particular, cytochrome P450 7A1 (CYP7A1), a key enzyme for cholesterol metabolism, was down…
cabdirect.org
elsevier.com
sci-hub.se 参考文章(29)
Desmet Vj, Histopathology of cholestasis. Pathology Research and Practice. ,vol. 79, pp. 233- ,(1995)
Hitomi Fukuda, Akihiko Katsurada, Nobuko Iritani, Nutritional and hormonal regulation of mRNA levels of lipogenic enzymes in primary cultures of rat hepatocytes. Journal of Biochemistry. ,vol. 111, pp. 25- 30 ,(1992) , 10.1093/OXFORDJOURNALS.JBCHEM.A123713
Merja Korkalainen, Jouko Tuomisto, Raimo Pohjanvirta, Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain Biochemical and Biophysical Research Communications. ,vol. 315, pp. 123- 131 ,(2004) , 10.1016/J.BBRC.2004.01.028
Renslow Sherer, HIV, HAART, and hyperlipidemia: balancing the effects. Journal of Acquired Immune Deficiency Syndromes. ,vol. 34, pp. 123- 129 ,(2003) , 10.1097/00126334-200310012-00005
David Y. Hui, Effects of HIV protease inhibitor therapy on lipid metabolism. Progress in Lipid Research. ,vol. 42, pp. 81- 92 ,(2003) , 10.1016/S0163-7827(02)00046-2
Eric S. Tien, John W. Davis, John P. Vanden Heuvel, Identification of the CREB-binding Protein/p300-interacting Protein CITED2 as a Peroxisome Proliferator-activated Receptor α Coregulator Journal of Biological Chemistry. ,vol. 279, pp. 24053- 24063 ,(2004) , 10.1074/JBC.M401489200
Rosa F. Yeh, Vincent E. Gaver, Kristine B. Patterson, Naser L. Rezk, Faustina Baxter-Meheux, Michael J. Blake, Joseph J. Eron, Cheri E. Klein, John C. Rublein, Angela D.M. Kashuba, Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers Journal of Acquired Immune Deficiency Syndromes. ,vol. 42, pp. 52- 60 ,(2006) , 10.1097/01.QAI.0000219774.20174.64
Pek Yee Lum, Yudong D. He, J. Greg Slatter, Jeffrey F. Waring, Nicollete Zelinsky, Guy Cavet, Xudong Dai, Olivia Fong, Rebecca Gum, Lixia Jin, Gary E. Adamson, Christopher J. Roberts, David B. Olsen, Daria J. Hazuda, Roger G. Ulrich, Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia Genomics. ,vol. 90, pp. 464- 473 ,(2007) , 10.1016/J.YGENO.2007.06.004
Eric S. Goetzman, Liqun Tian, Tim R. Nagy, Barbara A. Gower, Trenton R. Schoeb, Ada Elgavish, Edward P. Acosta, Michael S. Saag, Philip A. Wood, HIV protease inhibitor ritonavir induces lipoatrophy in male mice. AIDS Research and Human Retroviruses. ,vol. 19, pp. 1141- 1150 ,(2003) , 10.1089/088922203771881248
Sam Kacew, Confounding factors in toxicity testing Toxicology. ,vol. 160, pp. 87- 96 ,(2001) , 10.1016/S0300-483X(00)00440-6